Home
About us
Media
R&D Strengths
Bussiness
Partners
Contact Us
CN
OA Login
Email
Home
About Us
Profile
Chairman Message
History
Rewards & Recognition
Achievements
Organization Chart
Culture
Media
Press Releases
Social Media
Weekly
Monthly
R&D Strength
R&D Sector
R&D Center
R&D Teams
Facilities & Equipment
Bussiness
Project Transfer
Project Service
Partners
Contact Us
Contact Us
Recruitment
Tel
Support Hotline:
+86-10-82001093
QQ
QQ Online:
3247664159
WeChat
Scan the QR code
News Center
Press Releases
Social Media
Weekly
Monthly
News Center
Press Releases
Social Media
Weekly
Monthly
国家药监局综合司公开征求《已上市药品临床变更技术指导原则(征求意见稿)》意见
Time:2020-05-05
为做好《药品注册管理办法》配套文件制修订工作,国家药监局组织起草了《已上市药品临床变更技术指导原则(征求意见稿)》,现向社会公开征求意见,请于2020年5月30日将有关意见或建议以电子邮件形式反馈至xiesm@cde.org.cn,邮件标题请注明“已上市药品临床变更技术指导原则意见反馈”。
附件:已上市药品临床变更技术指导原则(征求意见稿)及起草说明
国家药监局综合司
2020年4月29日
Previous:Aerosol inhalation preparation has a bright market prospect
Next:孙达调研粤澳合作中医药科技产业园
Back to list
TEL
SMS
WeChat
Scan the WeChat QR code